Kimihide Kusafuka

Kimihide Kusafuka

Auto-generated profile, based on publicly available information

Kimihide Kusafuka

Department of Pathology, Shizuoka General Hospital, Shizuoka, Japan

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2021 in Histopathology
Verified
Journal Article
Closed access
PDF file
SNSatsuki Nakano
Satsuki Nakano
YOYoshihide Okumura
Yoshihide Okumura
TMTakayuki Murase
Takayuki Murase
TNToshitaka Nagao
Toshitaka Nagao
KKKimihide Kusafuka
Kimihide Kusafuka
HIHiroshi Inagaki
Hiroshi Inagaki

23 January 2020 in Head & Neck
Verified
Journal Article
Closed access
PDF file
KUKaori Ueda
Kaori Ueda
TMTakayuki Murase
Takayuki Murase
TNToshitaka Nagao
Toshitaka Nagao
KKKimihide Kusafuka
Kimihide Kusafuka
MUMakoto Urano
Makoto Urano
HIHiroshi Inagaki
Hiroshi Inagaki

3 February 2021 in American Journal of Surgical Pathology
Verified
Journal Article
Closed access
KKKimihide Dds Kusafuka
Kimihide Dds Kusafuka
KIKeiko Bs Ishino
Keiko Bs Ishino
MMMatsuyoshi Maeda
Matsuyoshi Maeda
KYKoji Dds Yamanegi
Koji Dds Yamanegi
SBSatoshi Baba
Satoshi Baba
MSMakoto Suzuki
Makoto Suzuki
Salivary duct carcinoma is a relatively uncommon malignancy of the salivary glands; however, it frequently occurs as a carcinomatous component of carcinoma ex pleomorphic adenoma. We previously reported salivary duct carcinoma with rhabdoid features (SDCRF) as an extremely rare subtype of salivary duct carcinoma, and that it occurred as a salivary counterpart of pleomorphic lobular carcinoma of the breast (PLCB). We collected new cases of SDCRF for this study, in which we examined a total of 17 cases immunohistochemically and genetically. As it is known that PLCB exhibits loss of or aberrant E-cadherin expression and carries nonsense/missense mutations in or deletion of the CDH1 gene, we examined the CDH1 gene status of our SDCRF cases. All of the examined SDCRF cases involved the diffuse proliferation of large ovoid cells with eosinophilic cytoplasm and eccentric nuclei, which displayed reduced cell-cell adhesion. Most cases were positive for pan-cytokeratin, androgen receptor, gross cystic disease fluid protein-15, SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1, and WI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4, whereas they were negative for vimentin. No and decreased/cytoplasmic E-cadherin expression was observed in 11 and 4 of 17 cases, respectively, whereas no and decreased/cytoplasmic β-catenin expression were observed in 10 and 5 of 17 cases, respectively. Among the 11 cases that could be genetically analyzed, a nonsense mutation (1 case), missense mutations (6 cases), and insertions (1 case) were detected in the CDH1 gene. In conclusion, we propose that SDCRF is the salivary counterpart of PLCB due to its morphology and immunophenotype, and the genetic status of CDH1.

1 November 2021 in Pathology - Research and Practice
Verified
Journal Article
Closed access
HYHidetaka Yamamoto
Hidetaka Yamamoto
KKKimihide Kusafuka
Kimihide Kusafuka
YNYui Nozaki
Yui Nozaki
TITomohiro Iwasaki
Tomohiro Iwasaki
MNMiwako Nogami
Miwako Nogami
YOYoshinao Oda
Yoshinao Oda

29 March 2022 in Head & Neck
Verified
Journal Article
Open access
KKKimihide Kusafuka
Kimihide Kusafuka
YSYoko Sato
Yoko Sato
ENEiji Nakatani
Eiji Nakatani
SBSatoshi Baba
Satoshi Baba
MMMatsuyoshi Maeda
Matsuyoshi Maeda
MSMakoto Suzuki
Makoto Suzuki
Background: Salivary duct carcinoma (SDC) is a high‐grade salivary malignancy that frequently occurs as the carcinomatous component of carcinoma ex pleomorphic adenoma. We herein examined the clinical factors affecting outcomes in a large cohort of SDC.Methods: We selected 304 SDC cases and investigated clinical characteristics and the factors affecting outcomes.Results: The median age of the cases examined was 68 years, the most common primary site was the parotid gland (238 cases), and there was a male predominance (M/F = 5:1). Outcomes were significantly worse when the primary tumor site was the minor salivary glands (SG) than when it was the major SG. Outcomes were also significantly worse in pN(+) cases (161 cases) than in pN0 cases, particularly those with a metastatic lymph node number ≥11. The cumulative incidence of relapse and distant metastases was significantly higher in stage IV cases than in stage 0–III cases.Conclusions: The absolute number of lymph node metastases, higher stages, and the minor SG as the primary tumor site were identified as factors affecting the outcome of SDC.